SRPT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

28.23

Margin Of Safety %

-24

Put/Call OI Ratio

0.72

EPS Next Q Diff

0.06

EPS Last/This Y

11.92

EPS This/Next Y

-2.34

Price

16.78

Target Price

22.09

Analyst Recom

2.73

Performance Q

-19.33

Upside

-324.7%

Beta

0.23

Ticker: SRPT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	SRPT	18.82	0.93	0.17	78906
2026-07-14	SRPT	17.97	0.93	0.12	79416
2026-07-15	SRPT	17.61	0.92	0.24	79994
2026-07-16	SRPT	17.23	0.91	0.15	81169
2026-07-17	SRPT	17.2	0.90	0.10	81682
2026-07-20	SRPT	16.83	0.94	0.10	75901
2026-07-21	SRPT	16.2	0.92	0.17	77144
2026-07-22	SRPT	15.81	0.89	0.12	79502
2026-07-23	SRPT	15.87	0.88	0.22	80211
2026-07-24	SRPT	15.67	0.86	0.21	80727
2026-07-27	SRPT	15.89	0.86	0.21	79589
2026-07-28	SRPT	15.46	0.85	0.27	80827
2026-07-29	SRPT	15.53	0.84	0.11	83263
2026-07-30	SRPT	15.56	0.84	0.47	83707
2026-07-31	SRPT	14.85	0.83	0.28	84624
2026-08-03	SRPT	15.89	0.86	0.16	82726
2026-08-04	SRPT	16.39	0.80	0.07	87246
2026-08-05	SRPT	15.9	0.77	0.72	89967
2026-08-06	SRPT	16.77	0.77	0.21	93676
2026-08-07	SRPT	16.78	0.72	0.08	98949
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	SRPT	18.83	-75.3	-	4.84
2026-07-14	SRPT	17.95	-75.9	-	4.81
2026-07-15	SRPT	17.60	-75.9	-	4.81
2026-07-16	SRPT	17.24	-75.9	-	4.81
2026-07-17	SRPT	17.20	-75.9	-	4.81
2026-07-20	SRPT	16.83	-75.9	-	4.81
2026-07-21	SRPT	16.21	-75.9	-	4.79
2026-07-22	SRPT	15.81	-75.9	-	4.79
2026-07-23	SRPT	15.87	-75.9	-	4.79
2026-07-24	SRPT	15.66	-75.9	-	4.79
2026-07-27	SRPT	15.89	-75.9	-	4.79
2026-07-28	SRPT	15.45	-75.9	-	4.79
2026-07-29	SRPT	15.53	-75.9	-	4.79
2026-07-30	SRPT	15.56	-75.9	-	4.79
2026-07-31	SRPT	14.85	-75.9	-	4.79
2026-08-03	SRPT	15.88	-75.9	-	4.79
2026-08-04	SRPT	15.88	-75.9	-	4.79
2026-08-05	SRPT	15.92	-75.9	-	4.79
2026-08-06	SRPT	16.79	-75.9	-	4.79
2026-08-07	SRPT	16.78	-75.9	-	4.79
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	SRPT	-0.16	12.00	28.47
2026-07-14	SRPT	-0.16	12.00	28.47
2026-07-15	SRPT	-0.16	12.00	28.47
2026-07-16	SRPT	-0.16	12.00	28.47
2026-07-17	SRPT	-0.16	12.00	28.47
2026-07-20	SRPT	-0.16	12.04	28.47
2026-07-21	SRPT	-0.16	12.04	28.47
2026-07-22	SRPT	-0.16	12.04	28.47
2026-07-23	SRPT	-0.16	12.04	28.47
2026-07-24	SRPT	-0.16	12.04	28.47
2026-07-27	SRPT	-0.16	11.92	28.23
2026-07-28	SRPT	-0.16	11.92	28.23
2026-07-29	SRPT	-0.16	11.92	28.23
2026-07-30	SRPT	-0.16	11.92	28.23
2026-07-31	SRPT	-0.16	11.92	28.23
2026-08-03	SRPT	-0.16	12.50	28.23
2026-08-04	SRPT	-0.16	12.50	28.23
2026-08-05	SRPT	-0.16	12.50	28.23
2026-08-06	SRPT	-0.16	12.50	28.23
2026-08-07	SRPT	-0.16	12.50	28.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.42

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.48

Insider Transactions

-0.16

Institutional Transactions

12.5

Beta

0.23

Average Sales Estimate Current Quarter

365

Average Sales Estimate Next Quarter

370

Fair Value

12.82

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.3

Max Drawdown 5-Year %

-92.7

Target Price

22.09

P/E

Forward P/E

21.72

PEG

P/S

0.9

P/B

1.16

P/Free Cash Flow

27.36

EPS

-2.9

Average EPS Est. Cur. Y

4.79

EPS Next Y. (Est.)

2.45

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.48

Relative Volume

0.89

Return on Equity vs Sector %

-36.3

Return on Equity vs Industry %

-20.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

◆ SRPT Healthcare

$16.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

15/25

Volume

7/15

Valuation

15/20

TP/AR

0/10

Options

5/10

RSI

51.2

Range 1M

32.1%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

8/30

Estimates

1/20

Inst/Vol

5/15

Options

6/10

EPS Yr

146.9%

EPS NY

-76.9%

52W%

19.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +44.1% upside

Quality

6/30

Valuation

15/30

Growth

6/25

Stability

7/10

LT Trend

1/5

Upside

+44.1%

Quality

MoS

-24%

SRPT — P/E HistoricalBiotechnology

Sarepta Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 835

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

SRPT

Latest News

—

Caricamento notizie per SRPT…

stock quote shares SRPT – Sarepta Therapeutics, Inc. Stock Price stock today

news today SRPT – Sarepta Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SRPT – Sarepta Therapeutics, Inc. yahoo finance google finance

stock history SRPT – Sarepta Therapeutics, Inc. invest stock market

stock prices SRPT premarket after hours

ticker SRPT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SRPT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y